SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-002519
Filing Date
2023-01-05
Accepted
2023-01-05 17:14:05
Documents
14
Period of Report
2022-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d441257d8k.htm   iXBRL 8-K 31245
2 EX-99.1 d441257dex991.htm EX-99.1 12193
6 GRAPHIC g441257page1a.jpg GRAPHIC 9349
  Complete submission text file 0001193125-23-002519.txt   185375

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acor-20221231.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20221231_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20221231_pre.xml EX-101.PRE 11258
8 EXTRACTED XBRL INSTANCE DOCUMENT d441257d8k_htm.xml XML 3403
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 23512417
SIC: 2836 Biological Products, (No Diagnostic Substances)